Clearance Summary
LYMPHOCYTE TYPING, NEGATIVE CONTROL received FDA 510(k) clearance under submission number K761008, sponsored by Hyland Therapeutic Div., Travenol Laboratories. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1977-04-06.
- Submission: K761008
- Applicant / Sponsor: Hyland Therapeutic Div., Travenol Laboratories
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class I
- Regulation citation: 21 CFR 864.7675
- Decision date: 1977-04-06
Classification & Regulation
This clearance is catalogued under FDA product code LGO and 21 CFR 864.7675, within the Hematology review panel as a Class I device.